06/11/2025
4:00 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
5:06 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:05 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
4:07 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
3:25 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
4:24 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
4:52 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/12/2025
8:46 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2025
5:00 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
3:40 PM | BridgeBio Pharma (Filer)
| Form DEFA14A | |
05/06/2025
3:42 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/06/2025
3:45 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
5:01 AM | BridgeBio Pharma (Filer)
| Form DEF 14A | |
04/30/2025
5:02 AM | BridgeBio Pharma (Filer)
| Form ARS | |
04/16/2025
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
4:06 PM | BridgeBio Pharma (Filer)
| Form PRE 14A | |
04/14/2025
3:21 PM | BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2025
4:11 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
3:48 PM | BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025
3:54 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:32 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:09 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
5:03 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:28 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025
3:43 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:09 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
5:15 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/06/2025
3:06 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
8:09 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
7:22 PM | Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/27/2025
4:36 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
3:35 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
7:48 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:50 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:51 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:31 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
4:23 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
6:18 PM | BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Banks aren’t ready for this altcoin—are you? (Ad) While everyone's distracted by Bitcoin's moves, a stealth revolution is underway.
One altcoin is quietly positioning itself to overthrow the entire banking system. Click here to access the full report now. |
01/31/2025
6:18 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SCHEDULE 13D/A | |
01/30/2025
5:29 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
5:31 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/28/2025
3:18 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
3:53 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:43 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4/A | |
12/31/2024
4:52 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:18 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
6:05 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:57 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
7:00 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:06 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:13 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:15 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:24 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
11/06/2024
4:04 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
09/17/2024
5:44 PM | BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
5:41 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
| Form SC 13D/A | |
09/13/2024
4:04 PM | BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:42 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024
5:24 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:31 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:29 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:39 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:06 PM | BridgeBio Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
7:16 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2024
3:12 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:40 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:34 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:35 PM | BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
